Abstract
In our previous studies we found that administration of exogenous prolactin increased dopamine turnover in the terminal areas of the hypothalamic dopaminergic neurons controlling prolactin secretion from pituitary lactotrophs. In this study we investigated the effect of immunoneutralization of endogenous prolactin on the expression of FRAs in the tuberoinfundibular dopaminergic (TIDA), tuberohypophysial dopaminergic (THDA), and periventricular hypothalamic dopaminergic (PHDA) subpopulations of the hypothalamic dopaminergic neurons.
Female rats were ovariectomized on d 0 of the experiment. At 1000 h of d 10, all animals were injected with 20 µg of 17-beta-estradiol sc to induce a proestrous-like surge of prolactin at 1700 h the next day. At 1000 h on d 11, half of the animals were injected with 200 µL of rabbit anti-rat prolactin antiserum ip, while the controls received normal rabbit serum. Groups of animals were sacrificed for immunocytochemistry in 2 h intervals between 1300 and 2100 h. Double-label immunocytochemistry for FRAs and tyrosine hydroxylase (TH) was performed and the results are presented as percentage of TH-immunoreactive neurons expressing FRAs.
In the control animals, expression of FRAs decreased at 1500 h, gradually increased by 1900 h, but was lower than the basal levels by 2100 h. Expression of FRAs was significantly lower at 1900 h in the PHDA, THDA and TIDA neurons of prolactin antiserum treated rats than in the controls.
These results indicate that elimination of endogenous prolactin from the circulation lowers the activity and/or prevents the reactivation of neuroendocrine dopaminergic neurons at the beginning of the dark phase.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
MacLeod, R. M. and Lehmeyer, J. E. (1974). Endocrinology 94, 1077–1085.
Zoli, M., Agnati, L. F., Tinner, B., Steinbusch, H. W. M., and Fuxe, K. (1993). J. Chem. Neuroanat. 6, 293–310.
Goudreau, J. L., Falls, W. M., Lookingland, K. J., and Moore, K. E. (1995). Neuroendocrin. 62, 147–154.
Goudreau, J. L., Lindley, S. E., Lookingland, K. J., and Moore, K. E. (1992). Neuroendocrin. 56, 100–105.
Murai, I. and Ben-Jonathan, N. (1986). Neuroendocrinology 43, 453–458.
Murai, I. and Ben-Jonathan, N. (1987). Brain Res. 420, 227–232.
DeMaria, J. E., Zelena, D., Vecsernyés, M., Nagy, G. M., and Freeman, M. E. (1998). Brain Res. 806, 89–94.
Racké, K., Hering, B., and Ziegler, K. (1990). Naunyn Schmiedebergs Arch. Pharmacol. 341, 182–185.
Timmerman, W., Deinum, M. E., Westerink, B. H., and Schuiling, G. A. (1995). Neurosci. Lett. 195, 113–116.
Demarest, K. T., Duda, N. J., Riegle, G. D., and Moore, K. E. (1983). Brain Res. 272, 175–178.
Demarest, K. T., Riegle, G. D., and Moore, K. E. (1984). Neuroendocrinology 39, 193–200.
Demarest, K. T., Moore, K. E., and Riegle, G. D. (1987). Neuroendocrinology 45, 227–232.
Lerant, A. and Freeman, M. E. (1998). Brain Res. 802, 141–154.
DeMaria, J. E., Lerant, A., and Freeman, M. E. (1999). Brain Res. 837, 236–241.
Lerant, A., Kanyicska, B., and Freeman, M. E. (2001). Brain Res. 904, 259–269.
Hoffman, G. E., Smith, M. S., and Verbalis, J. G. (1993). Front. Neuroendocrinol. 14, 173–213.
Hoffman, G. E., Le, W.-W., Abbud, R., Lee, W.-S., and Smith, M. S. (1994). Brain Res. 654, 207–215.
Lee, W.-S., Abbud, R., Smith, M. S., and Hoffman, G. E. (1992). Endocrinology 130, 3101–3103.
Hughes, P. and Dragunow, M. (1995). Pharmacol. Rev. 47, 133–178.
Lerant, A. and Freeman, M. E. (1997). Neuroendocrin. 65, 436–445.
Lerant, A., Kanyicska, B., and Freeman, M. E. (2001). Brain Res. 904, 259–269.
Freeman, M. E., Kanyicska, B., Lerant, A., and Nagy, G. (2000). Physiol. Rev. 80, 1523–1631.
Neill, J. D., Freeman, M. E., and Tillson, S. A. (1971). Endocrinology 89, 1148–1453.
Lerant, A. and Freeman, M. E. (1997). Neuroendocrinology 65, 436–445.
DeMaria, J. E., Nagy, G. M., and Freeman, M. E. (2000). Endocrine 12, 333–337.
Lerant, A., Herman, M. E., and Freeman, M. E. (1996). Endocrinology 137, 3621–3628.
Moore, K. E. (1987). Biology of Reproduction 36, 47–58.
Demarest K, Riegle G, and Moore K (1984). Neuroendocrinology 38, 467–475.
Arbogast, L. A. and Voogt, J. L. (1995). Endocrine 3, 801–806.
DeMaria, J. E., Livingstone, J. D., and Freeman, M. E. (1998). Neuroendocrin. 67, 377–383.
Hentschel, K., Fleckenstein, A. E., Toney, T. W., Lawson, D. M., Moore, K. E., and Lookingland, K. J. (2000). Brain Res. 852, 28–36.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lerant, A.A., DeMaria, J.E. & Freeman, M.E. Decreased expression of fos-related antigens (FRAs) in the hypothalamic dopaminergic neurons after immunoneutralization of endogenous prolactin. Endocr 16, 181–187 (2001). https://doi.org/10.1385/ENDO:16:3:181
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:16:3:181